Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells.
Möckelmann N, Rieckmann T, Busch CJ, Becker B, Gleißner L, Hoffer K, Omniczynski M, Steinmeister L, Laban S, Grénman R, Petersen C, Rothkamm K, Dikomey E, Knecht R, Kriegs M.
Möckelmann N, et al.
Oncotarget. 2016 Apr 26;7(17):23542-51. doi: 10.18632/oncotarget.8275.
Oncotarget. 2016.
PMID: 27015558
Free PMC article.